山崩 发表于 2025-3-28 17:17:10

http://reply.papertrans.cn/48/4733/473221/473221_41.png

Heart-Rate 发表于 2025-3-28 19:38:24

http://reply.papertrans.cn/48/4733/473221/473221_42.png

臆断 发表于 2025-3-29 00:39:19

http://reply.papertrans.cn/48/4733/473221/473221_43.png

保留 发表于 2025-3-29 03:43:24

Management of Ovarian Cancer: Clinical Trials,y. What began as a hypothesis, based on a theoretical mathematical model, has been translated into a 67-mo median survival for women with small-volume residual advanced ovarian cancer ...The three major randomized clinical trials on ovarian cancer are detailed in this chapter. The methodology and ou

pancreas 发表于 2025-3-29 09:05:12

http://reply.papertrans.cn/48/4733/473221/473221_45.png

信任 发表于 2025-3-29 15:05:48

Immunobiology and Intraperitoneal Immunobiologics in Ovarian Cancer,t of ovarian cancer, as well as other malignancies. Extensive studies have provided support for antigen-driven T-cell activation in vivo. The number of known tumor antigen epitopes is expanding, although advances in this area remain behind that of melanoma. Evidence suggests that the tumor environme
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Intraperitoneal Cancer Therapy; C. William Helm,Robert P. Edwards (Vice Chairman o Book 2007 Humana Press 2007 cancer.carcinoma.clinical t